KIDS logo

ORTHOPEDIATRICS CORP

KIDSNASDAQ
🏆 #2864 by market capEarnings Oct 26 · PostUS Equity
$162.69▲ $7.96 (+4.89%)
Simulated price
🔔
Track KIDS
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 4.9%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$589M
Small Cap
📈Revenue Growth (YoY)
+14.5%
Healthy
📊Gross Margin
73.7%
High
💵FCF Margin
—
⚖️P/S Ratio
2.3x
Cheap
Otter Score
76
Good
No chart data available for KIDS.

Trading Snapshot

Day Range
$162.14 – $163.79
52-Week Range
$14.42 – $26.74
Volume
$3.08B
Avg Volume
$3.07B
Shares Outstanding
25.7M
Next Earnings
Nov 10, 2026

Fundamentals Snapshot

Annual Revenue
$236M
Last Q Revenue
$71M
P/E Ratio
—
P/S Ratio
2.3x
EPS (TTM)
$-1.68
Dividend Yield
—
Dilution (1yr)
+1.7%

Why Investors Own KIDS

  • ✓High-growth profile — revenue up +50.5% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 59% gross margin and 20% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

KIDS logo

ORTHOPEDIATRICS CORP

KIDS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$236M▲ +15.4% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
73.1%▲ +0.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$29M▼ −1.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$16M▼ −61.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
23.6M▲ +1.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$80M▼ −$43M YoY
StockOtter · stockotter.space

About ORTHOPEDIATRICS CORP

OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
76/100

Analyst Price Target

ⓘ
Average Target
$168.71
▲ +3.7% Upside
High Target$192.40
Low Target$135.40
Based on 23 analysts

Latest News & Updates

🚀
Barron’s·2h ago

ORTHOPEDIATRICS CORP tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Bloomberg·5h ago

Analysts lift KIDS price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Barron’s·1d ago

ORTHOPEDIATRICS CORP announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.